Comorbidity Increases the Risk of Invasive Meningococcal Disease in Adults

被引:8
作者
Lundbo, Lene Fogt [1 ]
Harboe, Zitta Barrella [2 ,3 ,4 ]
Sandholdt, Hakon [1 ]
Smith-Hansen, Lars [5 ]
Valentiner-Branth, Palle [6 ]
Hoffmann, Steen [7 ]
Benfield, Thomas [1 ,4 ]
机构
[1] Copenhagen Univ Hosp Amager & Hvidovre, Ctr Res & Disrupt Infect Dis, Dept Infect Dis, Hvidovre, Denmark
[2] Copenhagen Univ Hosp North Zealand, Dept Pulm & Infect Dis, Copenhagen, Denmark
[3] Statens Serum Inst, Dept Microbiol Surveillance & Res, Copenhagen, Denmark
[4] Univ Copenhagen, Fac Hlth Sci, Dept Clin Med, Copenhagen, Denmark
[5] Copenhagen Univ Hosp Amager & Hvidovre, Dept Clin Res, Hvidovre, Denmark
[6] Statens Serum Inst, Dept Infect Dis Epidemiol & Prevent, Infect Dis Preparedness, Copenhagen, Denmark
[7] Statens Serum Inst, Dept Bacteria Parasites & Fungi, Infect Dis Preparedness, Copenhagen, Denmark
关键词
Neisseria meningitidis; sepsis; meningitis; comorbidity; IMMUNIZATION PRACTICES; ADVISORY-COMMITTEE; ASPLENIC PATIENTS; INFECTIONS; PREVENTION; RECOMMENDATIONS; IMMUNOGENICITY; VACCINES;
D O I
10.1093/cid/ciab856
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this Danish case-control-study that included >1200 cases over 4 decades, certain comorbidities increased risk of invasive meningococcal disease, ranging from a 2- to 40-fold increased risk. Vaccination and increased focus on appropriate medical care may be warranted in these populations. Background Risk of invasive meningococcal disease (IMD) is increased in patients with complement deficiency and human immunodeficiency virus (HIV) infection. Risk associated with comorbidity is not well described. Methods This was a nationwide adult case-control study. Cases for the period 1977-2018 were identified by the national meningococcus reference laboratory. Matched controls were identified by registry linkage. Comorbidities diagnosed prior to IMD were based on the International Classification of Diseases, Eighth or Tenth Revision. Odds ratios (ORs) with 95% confidence intervals (CIs) were estimated by logistic regression after adjustment for sex, age, and other comorbidities. Results We identified 1221 cases (45% male), with a median age of 45 years (interquartile range, 22-64 years). The dominant meningococcal serogroups were B (n = 738) and C (n = 337). Increased risk of IMD was associated with solid organ transplantation (SOT) (OR 40.47 [95% CI: 4.84-337.23]), hemolytic anemia (OR 7.56 [95% CI: 2.63-21.79]), renal disease (OR 2.95 [95% CI: 1.77-4.92]), liver disease (OR 2.54 [95% CI: 1.58-4.08]), cancer (OR 2.31 [95% CI: 1.85-2.89]), diabetes (OR 1.74 [95% CI: 1.27-2.39]), neurological disease (OR 1.72 [95% CI: 1.20-2.46]), and autoimmune disease (OR 1.70 [95% CI: 1.63-2.11]). Having 1, 2, and >= 3 comorbidities was associated with increased risk of IMD (ORs 1.6-3.5). Increased risk was not associated with specific serogroups. Conclusions This study of adults with IMD over 4 decades showed increased risk of IMD associated with renal disease, immunological disorders, liver disease, cancer, and SOT ranging from a 2- to 40-fold increased risk. Vaccination may be warranted in these populations.
引用
收藏
页码:125 / 130
页数:6
相关论文
共 50 条
[21]   Risk Factors for Contracting Invasive Meningococcal Disease and Related Mortality: A Systematic Literature Review and Meta-analysis [J].
Dubey, Himanshu ;
Oster, Philipp ;
Fazeli, Mir Sohail ;
Guedes, Sandra ;
Serafini, Paul ;
Leung, Lisa ;
Amiche, Amine .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 119 :1-9
[22]   Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature [J].
Guedes, Sandra ;
Bertrand-Gerentes, Isabelle ;
Evans, Keith ;
Coste, Florence ;
Oster, Philipp .
BMC PUBLIC HEALTH, 2022, 22 (01)
[23]   Invasive meningococcal disease burden and prophylaxis: update on serogroup B vaccination [J].
Caceres, Rosario ;
Guillen, Jaume ;
Gonzalez-Inchausti, Carmen ;
Gomez Sobrino, Mamen .
FARMACEUTICOS COMUNITARIOS, 2021, 13 (04) :28-42
[24]   The Burden of Pediatric Invasive Meningococcal Disease in Spain (2008-2013) [J].
Rivero-Calle, Irene ;
Vilanova-Trillo, Lucia ;
Pardo-Seco, Jacobo ;
Blanco Salvado, Lidia ;
Illade Quinteiro, Laura ;
Martinon-Torres, Federico .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (04) :407-413
[25]   Invasive Meningococcal Disease in Childhood [J].
Brayer, Anne F. ;
Humiston, Sharon G. .
PEDIATRICS IN REVIEW, 2011, 32 (04) :152-160
[26]   Invasive Pneumococcal and Meningococcal Disease [J].
Fitzgerald, Deirdre ;
Waterer, Grant W. .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2019, 33 (04) :1125-+
[27]   The Disease Burden of Invasive Meningococcal Serogroup B Disease in Canada [J].
Bettinger, Julie A. ;
Scheifele, David W. ;
Le Saux, Nicole ;
Halperin, Scott A. ;
Vaudry, Wendy ;
Tsang, Raymond .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (01) :E20-E25
[28]   Outcomes of Invasive Meningococcal Disease in Adults and Children in Canada Between 2002 and 2011: A Prospective Cohort Study [J].
Sadarangani, Manish ;
Scheifele, David W. ;
Halperin, Scott A. ;
Vaudry, Wendy ;
Le Saux, Nicole ;
Tsang, Raymond ;
Bettinger, Julie A. .
CLINICAL INFECTIOUS DISEASES, 2015, 60 (08) :E27-E35
[29]   Quadrivalent Conjugate Vaccine and Invasive Meningococcal Disease in US Adolescents and Young Adults [J].
Shin, Thomas ;
Wells, Chad R. ;
Shoukat, Affan ;
Potter-Schwartz, Lilia ;
Langevin, Edith ;
Langley, Joanne M. ;
Galvani, Alison P. ;
Moghadas, Seyed M. .
JAMA NETWORK OPEN, 2024, 7 (11) :e2443551
[30]   Invasive Meningococcal Disease and Meningococcal Serogroup B Vaccination in Adults and Their Offspring: Knowledge, Attitudes, and Practices in Italy (2019) [J].
Ricco, Matteo ;
Cerviere, Milena Pia ;
Marchesi, Federico ;
Bottazzoli, Marco .
VACCINES, 2023, 11 (03)